Clinical Trial Update: Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating splenic irradiation with nanoliposomal irinotecan plus 5-FU and leucovorin for metastatic pancreatic adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• Leucovorin (folinic acid)
• Nanoliposomal irinotecan (irinotecan liposomal)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: UNKNOWN